Earnings Feed
Start Free
BioPharmX Corp·4

Dec 22, 6:07 PM ET

Morlock Stephen 4

4 · BioPharmX Corp · Filed Dec 22, 2017

Insider Transaction Report

Form 4
Period: 2017-12-20
BioPharmX CorpBPMX
Morlock Stephen
Director
Transactions
  • Award

    Director Stock Option (right to buy)

    2017-12-20+450,000→ 450,000 total
    Exercise: $0.10Exp: 2027-12-20→ Common Stock (450,000 underlying)
  • Award

    Director Stock Option (right to buy)

    2017-12-20+205,000→ 205,000 total
    Exercise: $0.20Exp: 2027-12-20→ Common Stock (205,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable ratably over 12 months

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4